- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01224548
Multicenter Worksite Nutrition Study (WNS2)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to study the weight loss and other potential benefits of low fat vegan diet as compared to the standard American diet in a randomized, controlled and multi-centered workplace setting.
The 10 months study involves 5 vegan sites and 5 control sites generated through a random process after recruitment. The vegan sites will receive low fat vegan diet instructions and weekly group sessions starting from the January, 2011. The control sites will also receive identical instructions starting from the 5th month and lasting for 18 weeks.
For each participant at baseline and week 18 a blood test will be conducted, along with blood pressure, weight, hip and waist measurements. A questionnaire will also be administered during these time points to assess dietary intake, work productivity, quality of life, and healthcare utilization. At the end of one year, information about health insurance utilization will be obtained from Health Maintenance Organization(HMO) or Preferred Provider Organization(PPO) for each participant.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Arizona
-
Tucson, Arizona, United States, 85710
- Tucson
-
-
California
-
San Diego, California, United States, 92064
- San Diego
-
-
Florida
-
Lakeland, Florida, United States, 33811
- Lakeland
-
-
Georgia
-
Macon, Georgia, United States, 31295
- Macon
-
-
Maryland
-
Chevy Chase, Maryland, United States, 20815
- Chevy Chase
-
-
New York
-
Buffalo, New York, United States, 14068
- Buffalo
-
Woodbury, New York, United States, 11797
- Woodbury
-
-
Texas
-
Dallas, Texas, United States, 75244
- Dallas
-
-
Virginia
-
Fredericksburg, Virginia, United States, 22412
- Fredericksburg
-
Virginia Beach, Virginia, United States, 23454
- Virginia Beach
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Paid employee at a participating GEICO worksite for at least 6 months
- Currently a full-time employee at GEICO working for GEICO (at least 38.75 hours/week)
- Age of at least 18 years
- Ability and willingness to participate in all components of the study
- A willingness to be assigned to the vegan diet group or the control group
- Body mass index ≥ 25 kg/m2 and/or a diagnosis of type 2 diabetes mellitus, as defined by a fasting plasma glucose concentration ≥ 126 mg/dl on two occasions or a prior physician's diagnosis of type 2 diabetes
Exclusion Criteria:
- A history of alcohol abuse or dependency followed by any current use
- Current or unresolved past drug abuse
- Pregnancy or plans to become pregnant in the next 12 months
- Intention to leave GEICO in the next 12 months
- History of severe mental illness
- Unstable medical status
- Already following a low-fat, vegetarian diet
- An inordinate fear of blood draws
- Previously participated in GEICO two site study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: vegan group
participants from sites of this group will receive vegan nutritional intervention starting from Feb 2011
|
weekly 1-hr instructions including vegan nutritional information and cooking instructions.
vegan menu will be made available at the cafeteria
no intervention in until June 2011.
The control group start vegan diet in July 2011.
|
No Intervention: control group
participants from sites of the control group will not receive the same nutritional information until June 2011
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
weight
Time Frame: 0 months
|
body weight at baseline
|
0 months
|
weight
Time Frame: 18 weeks
|
body weight at the end of 4 months
|
18 weeks
|
weight
Time Frame: 10 months
|
body weight at the end of 12 months
|
10 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
blood pressure
Time Frame: 0 months
|
diastolic and systolic blood pressures at baseline
|
0 months
|
blood pressure
Time Frame: 18 weeks
|
diastolic and systolic blood pressures at the end of 4 months
|
18 weeks
|
blood pressure
Time Frame: 10 months
|
diastolic and systolic blood pressures at the end of 12 months
|
10 months
|
waist circumference
Time Frame: 0 month
|
measurement of waist circumference at baseline
|
0 month
|
waist circumference
Time Frame: 18 weeks
|
measurement of waist circumference at 4 months
|
18 weeks
|
waist circumference
Time Frame: 10 months
|
measurement of waist circumference at 12 months
|
10 months
|
absenteeism
Time Frame: 0 month
|
number of days absent because of sickness over the past 6 months, surveyed at baseline
|
0 month
|
absenteeism
Time Frame: 18 weeks
|
number of days absent because of sickness over the past 4 months, surveyed at the end of 4 months.
|
18 weeks
|
absenteeism
Time Frame: 10 months
|
number of days absent because of sickness over the past 6 months, surveyed at the end of 12 months.
|
10 months
|
health insurance utilization
Time Frame: 0 month
|
categorized payments by health insurance company for health-related coverage over the past 12 months, surveyed at baseline
|
0 month
|
healthy insurance utilization
Time Frame: 12 months
|
categorized payments by health insurance company for health-related coverage over the past 12 months, surveyed at the end of 12 months
|
12 months
|
blood lipid panel
Time Frame: 0 month
|
blood test of Low Density Lipoprotein (LDL), High Density Lipoprotein (HDL), total cholesterol, and triglyceride at baseline
|
0 month
|
blood lipid panel
Time Frame: 18 weeks
|
blood test of Low Density Lipoprotein (LDL), High Density Lipoprotein (HDL), total cholesterol, and triglyceride at the end of 4 months
|
18 weeks
|
blood lipid panel
Time Frame: 10 months
|
blood test of Low Density Lipoprotein (LDL), High Density Lipoprotein (HDL), total cholesterol, and triglyceride at the end of 12 months
|
10 months
|
quality of life
Time Frame: 0 month
|
questionnaire on quality of life measurements surveyed at baseline
|
0 month
|
quality of life
Time Frame: 18 weeks
|
questionnaire on quality of life measurements surveyed at the end of 4 months
|
18 weeks
|
quality of life
Time Frame: 10 months
|
questionnaire on quality of life measurements surveyed at the end of 12 months
|
10 months
|
hemoglobin A1c
Time Frame: 0 month
|
blood test of hemoglobin A1c level (for diabetic participants only) at baseline
|
0 month
|
hemoglobin A1c
Time Frame: 18 weeks
|
blood test of hemoglobin A1c level (for diabetic participants only) at the end of 4 months
|
18 weeks
|
hemoglobin A1c
Time Frame: 10 months
|
blood test of hemoglobin A1c level (for diabetic participants only) at the end of 12 months
|
10 months
|
hip circumference
Time Frame: 0 month
|
measurement of hip circumference at baseline
|
0 month
|
hip circumference
Time Frame: 18 weeks
|
measurement of hip circumference at the end of 4 months
|
18 weeks
|
hip circumference
Time Frame: 10 months
|
measurement of hip circumference at the end of 12 months
|
10 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Neal Barnard, M.D., Washington Center for Clinical Research
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- WCCR-WNS2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
University of Trás-os-Montes and Alto DouroCompletedType 2 Diabetes Mellitus | Diabetes-Related ComplicationsPortugal
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
VeraLight, Inc.InLight SolutionsUnknownGestational Diabetes | Insulin Dependent Diabetes | Non Insulin Dependent DiabetesUnited States
-
Garvan Institute of Medical ResearchWeizmann Institute of ScienceActive, not recruitingType 2 Diabetes Mellitus | Pre DiabetesAustralia
-
Oregon State UniversitySanofiCompletedType I or Type II Diabetes (Excludes Gestational Diabetes)
-
Taichung Veterans General HospitalNational Health Research Institutes, TaiwanRecruitingDiabetes Complications | Type 2 Diabetes | Maturity-Onset Diabetes of the Young (MODY)Taiwan
-
University of RoehamptonRecruitingType2 Diabetes Mellitus | Pre DiabetesUnited Kingdom
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
Clinical Trials on vegan instruction and food accessibility
-
University of FloridaCompletedMeningococcal VaccineUnited States
-
VA Pittsburgh Healthcare SystemUniversity of PittsburghCompleted
-
VA Office of Research and DevelopmentCompletedUse of Power Wheelchairs and Power Seat FunctionsUnited States
-
Federal University of São PauloUnknownLower Urinary Tract Symptoms | Urinary Incontinence | Urination Disorders | Urinary Incontinence, StressBrazil
-
University of BariUniversity of Bologna; Federico II University; University Of Perugia; University... and other collaboratorsUnknownDiet and Human MicrobiotaItaly
-
Universidad Autonoma de ChihuahuaCompletedHeart Diseases | HivMexico
-
McGill UniversityUniversity of Toronto; University of Ottawa; Concordia University, MontrealRecruitingADHD | Mindfulness | Nonsuicidal Self-injuryCanada
-
Tel-Aviv Sourasky Medical CenterKaMaH - The Center for Health-Promoting TherapiesRecruitingIndolent LymphomaIsrael
-
Penn State UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Physicians Committee for Responsible MedicineActive, not recruiting